« Back to Record
De Cock, E., Hutton, J., Canney, P., Body, J.-J., Barrett-Lee, P., Neary, M., & Lewis, G. (2005). Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. Clinical therapeutics, 27(8), 1295-1310. doi:10.1016/j.clinthera.2005.08.006
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83373



